Novartis AG
LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF
Last updated:
Abstract:
The present invention relates, in part, to compositions and methods for enhancement of an immune response by partial mTOR inhibition, e.g., with low, immune enhancing, doses of an mTOR inhibitor, such as RAD001.
Status:
Application
Type:
Utility
Filling date:
22 Mar 2019
Issue date:
20 Feb 2020